Year: 2023

Diaccurate Announces Updated Data on its Novel PAM Pathway Inhibitor DIACC3010 in Patients with ER+ HER2- Metastatic Breast Cancer to be Presented at AACR 2023

Diaccurate Announces Updated Data on its Novel PAM Pathway Inhibitor DIACC3010 in Patients with ER+ HER2- Metastatic Breast Cancer to...

BioAdaptives Announces Signing of Non-Exclusive Marketing Agreement With World Wellness, LLC for the Launching of Weight Management System Including an AI Supported Body Composition Measuring App and New Health Products

error: Content is protected !!